Trefoil factor 3 stimulates human and rodent pancreatic islet β-cell replication with retention of function

Patrick T. Fueger, Jonathan C. Schisler, Danhong Lu, Daniella A. Babu, Raghu Mirmira, Christopher B. Newgard, Hans E. Hohmeier

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Both major forms of diabetes involve a decline in β-cell mass, mediated by autoimmune destruction of insulin-producing cells in type 1 diabetes and by increased rates of apoptosis secondary to metabolic stress in type 2 diabetes. Methods for controlled expansion of β-cell mass are currently not available but would have great potential utility for treatment of these diseases. In the current study, we demonstrate that overexpression of trefoil factor 3 (TFF3) in rat pancreatic islets results in a 4- to 5-fold increase in [3H]thymidine incorporation, with full retention of glucose-stimulated insulin secretion. This increase was almost exclusively due to stimulation of β-cell replication, as demonstrated by studies of bromodeoxyuridine incorporation and co-immunofluorescence analysis with anti-bromodeoxyuridine and antiinsulin or antiglucagon antibodies. The proliferative effect of TFF3 required the presence of serum or 0.5 ng/ml epidermal growth factor. The ability of TFF3 overexpression to stimulate proliferation of rat islets in serum was abolished by the addition of epidermal growth factor receptor antagonist AG1478. Furthermore, TFF3-induced increases in [3H]thymidine incorporation in rat islets cultured in serum was blocked by overexpression of a dominant-negative Akt protein or treatment with triciribine, an Akt inhibitor. Finally, overexpression of TFF3 also caused a doubling of [3H]thymidine incorporation in human islets. In summary, our findings reveal a novel TFF3-mediated pathway for stimulation of β-cell replication that could ultimately be exploited for expansion or preservation of islet β-cell mass.

Original languageEnglish (US)
Pages (from-to)1251-1259
Number of pages9
JournalMolecular Endocrinology
Volume22
Issue number5
DOIs
StatePublished - May 2008
Externally publishedYes

Fingerprint

Islets of Langerhans
Rodentia
Thymidine
triciribine
Bromodeoxyuridine
Serum
Insulin
Physiological Stress
Type 1 Diabetes Mellitus
Epidermal Growth Factor Receptor
Epidermal Growth Factor
Type 2 Diabetes Mellitus
Fluorescent Antibody Technique
Trefoil Factor-3
Apoptosis
Glucose
Antibodies
Therapeutics
Proteins

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism

Cite this

Trefoil factor 3 stimulates human and rodent pancreatic islet β-cell replication with retention of function. / Fueger, Patrick T.; Schisler, Jonathan C.; Lu, Danhong; Babu, Daniella A.; Mirmira, Raghu; Newgard, Christopher B.; Hohmeier, Hans E.

In: Molecular Endocrinology, Vol. 22, No. 5, 05.2008, p. 1251-1259.

Research output: Contribution to journalArticle

Fueger, Patrick T. ; Schisler, Jonathan C. ; Lu, Danhong ; Babu, Daniella A. ; Mirmira, Raghu ; Newgard, Christopher B. ; Hohmeier, Hans E. / Trefoil factor 3 stimulates human and rodent pancreatic islet β-cell replication with retention of function. In: Molecular Endocrinology. 2008 ; Vol. 22, No. 5. pp. 1251-1259.
@article{d5fe1d1845b84c8abb00ca537a771eb7,
title = "Trefoil factor 3 stimulates human and rodent pancreatic islet β-cell replication with retention of function",
abstract = "Both major forms of diabetes involve a decline in β-cell mass, mediated by autoimmune destruction of insulin-producing cells in type 1 diabetes and by increased rates of apoptosis secondary to metabolic stress in type 2 diabetes. Methods for controlled expansion of β-cell mass are currently not available but would have great potential utility for treatment of these diseases. In the current study, we demonstrate that overexpression of trefoil factor 3 (TFF3) in rat pancreatic islets results in a 4- to 5-fold increase in [3H]thymidine incorporation, with full retention of glucose-stimulated insulin secretion. This increase was almost exclusively due to stimulation of β-cell replication, as demonstrated by studies of bromodeoxyuridine incorporation and co-immunofluorescence analysis with anti-bromodeoxyuridine and antiinsulin or antiglucagon antibodies. The proliferative effect of TFF3 required the presence of serum or 0.5 ng/ml epidermal growth factor. The ability of TFF3 overexpression to stimulate proliferation of rat islets in serum was abolished by the addition of epidermal growth factor receptor antagonist AG1478. Furthermore, TFF3-induced increases in [3H]thymidine incorporation in rat islets cultured in serum was blocked by overexpression of a dominant-negative Akt protein or treatment with triciribine, an Akt inhibitor. Finally, overexpression of TFF3 also caused a doubling of [3H]thymidine incorporation in human islets. In summary, our findings reveal a novel TFF3-mediated pathway for stimulation of β-cell replication that could ultimately be exploited for expansion or preservation of islet β-cell mass.",
author = "Fueger, {Patrick T.} and Schisler, {Jonathan C.} and Danhong Lu and Babu, {Daniella A.} and Raghu Mirmira and Newgard, {Christopher B.} and Hohmeier, {Hans E.}",
year = "2008",
month = "5",
doi = "10.1210/me.2007-0500",
language = "English (US)",
volume = "22",
pages = "1251--1259",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Trefoil factor 3 stimulates human and rodent pancreatic islet β-cell replication with retention of function

AU - Fueger, Patrick T.

AU - Schisler, Jonathan C.

AU - Lu, Danhong

AU - Babu, Daniella A.

AU - Mirmira, Raghu

AU - Newgard, Christopher B.

AU - Hohmeier, Hans E.

PY - 2008/5

Y1 - 2008/5

N2 - Both major forms of diabetes involve a decline in β-cell mass, mediated by autoimmune destruction of insulin-producing cells in type 1 diabetes and by increased rates of apoptosis secondary to metabolic stress in type 2 diabetes. Methods for controlled expansion of β-cell mass are currently not available but would have great potential utility for treatment of these diseases. In the current study, we demonstrate that overexpression of trefoil factor 3 (TFF3) in rat pancreatic islets results in a 4- to 5-fold increase in [3H]thymidine incorporation, with full retention of glucose-stimulated insulin secretion. This increase was almost exclusively due to stimulation of β-cell replication, as demonstrated by studies of bromodeoxyuridine incorporation and co-immunofluorescence analysis with anti-bromodeoxyuridine and antiinsulin or antiglucagon antibodies. The proliferative effect of TFF3 required the presence of serum or 0.5 ng/ml epidermal growth factor. The ability of TFF3 overexpression to stimulate proliferation of rat islets in serum was abolished by the addition of epidermal growth factor receptor antagonist AG1478. Furthermore, TFF3-induced increases in [3H]thymidine incorporation in rat islets cultured in serum was blocked by overexpression of a dominant-negative Akt protein or treatment with triciribine, an Akt inhibitor. Finally, overexpression of TFF3 also caused a doubling of [3H]thymidine incorporation in human islets. In summary, our findings reveal a novel TFF3-mediated pathway for stimulation of β-cell replication that could ultimately be exploited for expansion or preservation of islet β-cell mass.

AB - Both major forms of diabetes involve a decline in β-cell mass, mediated by autoimmune destruction of insulin-producing cells in type 1 diabetes and by increased rates of apoptosis secondary to metabolic stress in type 2 diabetes. Methods for controlled expansion of β-cell mass are currently not available but would have great potential utility for treatment of these diseases. In the current study, we demonstrate that overexpression of trefoil factor 3 (TFF3) in rat pancreatic islets results in a 4- to 5-fold increase in [3H]thymidine incorporation, with full retention of glucose-stimulated insulin secretion. This increase was almost exclusively due to stimulation of β-cell replication, as demonstrated by studies of bromodeoxyuridine incorporation and co-immunofluorescence analysis with anti-bromodeoxyuridine and antiinsulin or antiglucagon antibodies. The proliferative effect of TFF3 required the presence of serum or 0.5 ng/ml epidermal growth factor. The ability of TFF3 overexpression to stimulate proliferation of rat islets in serum was abolished by the addition of epidermal growth factor receptor antagonist AG1478. Furthermore, TFF3-induced increases in [3H]thymidine incorporation in rat islets cultured in serum was blocked by overexpression of a dominant-negative Akt protein or treatment with triciribine, an Akt inhibitor. Finally, overexpression of TFF3 also caused a doubling of [3H]thymidine incorporation in human islets. In summary, our findings reveal a novel TFF3-mediated pathway for stimulation of β-cell replication that could ultimately be exploited for expansion or preservation of islet β-cell mass.

UR - http://www.scopus.com/inward/record.url?scp=43049101101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049101101&partnerID=8YFLogxK

U2 - 10.1210/me.2007-0500

DO - 10.1210/me.2007-0500

M3 - Article

VL - 22

SP - 1251

EP - 1259

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 5

ER -